
|Articles|April 11, 2008
Inhalable insulin prescribing information revised to include lung malignancy occurrence
Pfizer revises package insert after reports of lung cancer in patients receiving their inhaled insulin.
Advertisement
Pfizer has issued letters to both healthcare professionals and patients to inform them of six reported cases of newly diagnosed primary lung malignancy during clinical trials in patients using their insulin human [rDNA origin] inhalation powder (
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
TrumpRx Officially Launches, Introduces Drug Prices
4
What the Newest Landmark PBM Reform Means for the Pharmacy Industry
5























